Literature DB >> 25910859

Intestinal colonization with phylogenetic group B2 Escherichia coli related to inflammatory bowel disease: a systematic review and meta-analysis.

Andreas Munk Petersen1, Sofie Ingdam Halkjær, Lise Lotte Gluud.   

Abstract

BACKGROUND AND OBJECTIVES: Increased numbers of Escherichia coli and, furthermore, specific subtypes of E. coli, such as E. coli of the phylogenetic groups B2 and D have been found in the intestine of patients with inflammatory bowel disease (IBD). In this review, we wanted to evaluate the relationship between B2 and D E. coli intestinal colonization and IBD.
METHODS: A systematic review with meta-analyses. We included studies comparing colonization with B2 and D E. coli in IBD patients and in controls. Random-effects and fixed-effect meta-analyses were performed.
RESULTS: We included 7 studies on 163 patients with IBD and 89 controls. Among IBD patients, 57 patients had ulcerative colitis (UC) and 95 Crohn's disease (CD). Random-effects meta-analysis showed that IBD patients were more likely to have B2 E. coli intestinal colonization compared with controls (odds ratio [OR]: 2.28; 95% confidence interval [CI]: 1.25-4.16). There was little between-study heterogeneity (I(2) = 0). The result was confirmed in subgroup analyses of patients with UC (OR: 3.58; 95% CI: 1.62-7.90), but not CD (OR: 1.94; 95% CI: 0.98-3.82). Intestinal colonization with phylogenetic group D E. coli was not found to be related to IBD, UC or CD.
CONCLUSIONS: Our study reveals that intestinal colonization with phylogenetic group B2 E. coli is associated with UC. Due to the design, we are unable to determine if the colonization with B2 E. coli leads to the development of the disease or the disease increases the risk of colonization with B2 E. coli.

Entities:  

Keywords:  Crohn’s disease; Escherichia coli; inflammatory bowel disease; ulcerative colitis

Mesh:

Year:  2015        PMID: 25910859     DOI: 10.3109/00365521.2015.1028993

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  9 in total

1.  Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation.

Authors:  Susana Fuentes; Noortje G Rossen; Mirjam J van der Spek; Jorn Ha Hartman; Laura Huuskonen; Katri Korpela; Jarkko Salojärvi; Steven Aalvink; Willem M de Vos; Geert R D'Haens; Erwin G Zoetendal; Cyriel Y Ponsioen
Journal:  ISME J       Date:  2017-04-11       Impact factor: 10.302

2.  Features of Gut Microbiome Associated With Responses to Fecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review.

Authors:  Jindong Zhang; Yangyang Guo; Liping Duan
Journal:  Front Med (Lausanne)       Date:  2022-05-26

3.  Synergic Interaction of Rifaximin and Mutaflor (Escherichia coli Nissle 1917) in the Treatment of Acetic Acid-Induced Colitis in Rats.

Authors:  Artur Dembiński; Zygmunt Warzecha; Piotr Ceranowicz; Marcin Dembiński; Jakub Cieszkowski; Tomasz Gosiewski; Małgorzata Bulanda; Beata Kuśnierz-Cabala; Krystyna Gałązka; Peter Christopher Konturek
Journal:  Gastroenterol Res Pract       Date:  2016-06-28       Impact factor: 2.260

4.  Escherichia coli Alpha-Hemolysin HlyA Induces Host Cell Polarity Changes, Epithelial Barrier Dysfunction and Cell Detachment in Human Colon Carcinoma Caco-2 Cell Model via PTEN-Dependent Dysregulation of Cell Junctions.

Authors:  Emanuel Schulz; Michael Schumann; Martina Schneemann; Violaine Dony; Anja Fromm; Oliver Nagel; Jörg-Dieter Schulzke; Roland Bücker
Journal:  Toxins (Basel)       Date:  2021-07-26       Impact factor: 4.546

5.  Prevalence, Abundance, and Virulence of Adherent-Invasive Escherichia coli in Ulcerative Colitis, Colorectal Cancer, and Coeliac Disease.

Authors:  Mireia López-Siles; Carla Camprubí-Font; Eva M Gómez Del Pulgar; Miriam Sabat Mir; David Busquets; Yolanda Sanz; Margarita Martinez-Medina
Journal:  Front Immunol       Date:  2022-03-10       Impact factor: 7.561

Review 6.  Chronic Gastrointestinal and Joint-Related Sequelae Associated with Common Foodborne Illnesses: A Scoping Review.

Authors:  Kristen Pogreba-Brown; Erika Austhof; Alexandra Armstrong; Kenzie Schaefer; Lorenzo Villa Zapata; D Jean McClelland; Michael B Batz; Maria Kuecken; Mark Riddle; Chad K Porter; Michael C Bazaco
Journal:  Foodborne Pathog Dis       Date:  2019-10-07       Impact factor: 3.788

Review 7.  The Gut Microbiota in Immune-Mediated Inflammatory Diseases.

Authors:  Jessica D Forbes; Gary Van Domselaar; Charles N Bernstein
Journal:  Front Microbiol       Date:  2016-07-11       Impact factor: 5.640

8.  Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.

Authors:  Michael Mintz; Shanawaj Khair; Suman Grewal; Joseph F LaComb; Jiyhe Park; Breana Channer; Ramona Rajapakse; Juan Carlos Bucobo; Jonathan M Buscaglia; Farah Monzur; Anupama Chawla; Jie Yang; Charlie E Robertson; Daniel N Frank; Ellen Li
Journal:  PLoS One       Date:  2018-01-31       Impact factor: 3.240

9.  High Abundance of Proteobacteria in Ileo-Anal Pouch Anastomosis and Increased Abundance of Fusobacteria Associated with Increased Pouch Inflammation.

Authors:  Andreas Munk Petersen; Hengameh Chloé Mirsepasi-Lauridsen; Marianne K Vester-Andersen; Nikolaj Sørensen; Karen Angeliki Krogfelt; Flemming Bendtsen
Journal:  Antibiotics (Basel)       Date:  2020-05-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.